VOYA INVESTMENT MANAGEMENT LLC - THERAVANCE INC ownership

THERAVANCE INC's ticker is THRX and the CUSIP is 88338T104. A total of 95 filers reported holding THERAVANCE INC in Q4 2015. The put-call ratio across all filers is 0.29 and the average weighting 0.2%.

Quarter-by-quarter ownership
VOYA INVESTMENT MANAGEMENT LLC ownership history of THERAVANCE INC
ValueSharesWeighting
Q4 2015$402,000
+46.7%
38,1280.0%0.00%0.0%
Q3 2015$274,000
-66.3%
38,128
-15.2%
0.00%
-50.0%
Q2 2015$813,000
+15.0%
44,9870.0%0.00%0.0%
Q1 2015$707,000
-23.8%
44,987
-31.4%
0.00%0.0%
Q4 2014$928,000
-70.7%
65,570
-64.6%
0.00%
-71.4%
Q3 2014$3,169,000
-42.7%
185,470
-0.1%
0.01%
-46.2%
Q2 2014$5,527,000
-3.3%
185,587
+0.5%
0.01%0.0%
Q1 2014$5,716,000
+8.5%
184,729
+25.0%
0.01%
+8.3%
Q4 2013$5,268,000
+20.8%
147,758
+38.5%
0.01%
+9.1%
Q3 2013$4,361,000
-28.8%
106,658
-32.9%
0.01%
-35.3%
Q2 2013$6,121,000158,8760.02%
Other shareholders
THERAVANCE INC shareholders Q4 2015
NameSharesValueWeighting ↓
Baupost Group 19,815,983$338,655,0005.90%
Litespeed Management, L.L.C. 2,670,695$45,642,0001.76%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 2,790,913$47,697,0001.76%
Proxima Capital Management, LLC 915,000$15,637,0001.69%
IRIDIAN ASSET MANAGEMENT LLC/CT 8,196,372$140,076,0001.44%
PERRY CAPITAL 1,831,099$31,293,0001.14%
Roundview Capital LLC 140,145$2,395,0001.08%
SECTORAL ASSET MANAGEMENT INC 971,438$16,602,0000.70%
Realm Partners LLC 139,982$2,392,0000.68%
BB BIOTECH AG 743,244$12,702,0000.52%
View complete list of THERAVANCE INC shareholders